IconxLab Competitors

Digital Dynamics, Inc. (DDI) is a fast-growing technology company that designs and builds best-in-class control hardware for the global semiconductor, metrology, display, solar, and other industries. DDI controls the complex equipment that enables the information age. DDI is an ISO 9001 certified company, with 40 years of design and manufacturing experience. DDI employs electrical, mechanical, software, and manufacturing engineers who create world leading controllers. All our products are designed and built in the USA at our facilities in Scotts Valley, California and shipped worldwide. We are 100% employee owned where all employees share the benefit of our rapid growth. DDI's new generation of EtherCAT I/O controls product line, the SuperIOr® Controller System, is designed for applications that require high speed distributed I/O and can simultaneously manage over 1000 inputs and 1000 outputs with sub-millisecond response times.

Innovative Labs is a leading contract development manufacturing organization helping health and wellness brands create high-absorption products—taking products from an initial idea all the way through production – at scale.

APEX is a patient-driven pharmaceutical company focused on optimizing the standard of mental health care with psilocybin by bringing data supported, clinically evaluated drugs to market for depression and anxiety in PTSD. Our strategy is focused on developing pharmaceutical products through a phased clinical program evaluating safety and efficacy across multiple indications, alongside a robust early access program. APEX has two GMP Certified drug assets. APEX-52 is microdose synthetic psilocybin for clinical evaluation, currently in active phase 2b trials, and APEX-25 is the company’s macro dose drug asset, developed for in-clinic dosing with assisted psychotherapy. APEX recently launched North America’s first take-home psilocybin trial, and received approval for the world’s largest psilocybin clinical trial to-date both evaluating APEX-52 in the treatment of anxiety and depression in diagnosed PTSD. APEX is driven by an experienced and passionate leadership team from the Veteran community, healthcare, drug policy and emerging sectors who want to make a difference and disrupt the $380+ billion global mental health market. Find out more at apexlabs.com